Skip to content

Treatment of essential hand tremor: Dysport versus propranolol

A clinical trial: comparative effectiveness of oral propranolol and Dysport injection on tremor severity in essential hand tremor

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201607022415N2
Enrollment
78
Registered
2016-08-22
Start date
2016-08-05
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

essential hand tremor. Essential tremor

Interventions

Intervention 1: Dysport intramuscular injection in forearm 100-150 unit once. Intervention 2: tablet propranolol 40-160 mg daily for 3 months.
Treatment - Drugs
Dysport intramuscular injection in forearm 100-150 unit once
tablet propranolol 40-160 mg daily for 3 months

Sponsors

Vice chancellor for research, army university of medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: essential hand tremor with severity equal or greater than 2 according to tremor research group essential tremor rating assessment scale (TETRAS) version 3.1 (paragraph 4); normal thyroid function test; age higher than 18 years; exclusion criteria: drug induced tremor; pregnancy and lactation; allergy to cow milk protein; propranolol contraindications for example heart block, congestive heart failure, diabetes melitus, asthma and etc; history of botulinum injection in upper limb; recent botulinum injection in any part of body since 8 months ago; allergy to botulinum; history of myasthenia gravis or suspicious to myasthenia gravis; parkinson disease; use of anti-dopaminergic medications

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Hand tremor severity. Timepoint: before treatment, one and two and three months following the start of treatment. Method of measurement: tremor research group essential tremor rating assessment scale (TETRAS).;Quality of life. Timepoint: before treatment, two months following start of treatment. Method of measurement: short form 36 (SF-36) quality of life questionnaire.

Secondary

MeasureTime frame
Side effects. Timepoint: one and two and three months following start of treatment. Method of measurement: history taking.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaeed Amiri

Army university of medical sciences

dr.saeed.amiri@gmail.com+98 21 8833 7920

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026